Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated …
P Karakasis, N Ktenopoulos, K Pamporis… - Journal of Clinical …, 2024 - mdpi.com
Background: Real-world data show limited utilization of direct oral anticoagulants (DO-ACs)
in obese patients (body mass index [BMI]≥ 30 kg/m2) due to concerns regarding their …
in obese patients (body mass index [BMI]≥ 30 kg/m2) due to concerns regarding their …